Introduction
============

Addressing rising rates of antimicrobial resistance (AMR) is a top challenge for the Canadian health system. Drug resistance is a naturally occurring phenomenon, whereby microbes evolve to become resistant to the antimicrobial drugs that we depend on to treat infections. Human actions -- particularly the overuse, misuse and abuse of antimicrobials in humans, animals and agriculture -- have accelerated this process ([@R20]).

AMR will have severe health and economic consequences; rising AMR jeopardizes future health system capabilities in Canada. Effective antimicrobials are needed for a range of routine medical procedures, including surgeries and chemotherapy treatments. As resistance becomes widespread, our ability to carry out these procedures is threatened. Health system costs will also increase because patients with resistant infections are more expensive to treat. The Council of Canadian Academies ([@R3]) estimates that AMR was responsible for 5,400 deaths and 880,000 days in hospital in 2018. Meanwhile, the Organisation for Economic Cooperation and Development ([@R28]) estimates that the effects of AMR cost the health systems of developed countries US\$3.5 billion per year, and the [@R3] calculated that AMR reduced Canada\'s GDP by CA\$2 billion in 2018.

Although antimicrobials are life-saving drugs, a large proportion of global antimicrobial use is inappropriate. Antibiotics, which treat bacterial infections, are commonly used in Canada and the US to treat conditions caused by microbes for which these are totally ineffective ([@R4]). Close to half of Ontario seniors are given antibiotics for respiratory tract infections that are not caused by bacteria ([@R34]). The leading strategy for tackling AMR is education with the goal of reducing the inappropriate use of antimicrobials through increased provider and patient knowledge ([@R38], [@R37]). However, drug resistance in Canada is part of a larger global problem, and investments, coordination and political support for policy interventions are needed to collectively address AMR at all levels of the health system.

To date, it has been difficult to take stock of organized efforts to address AMR in Canada, or to identify policies and programs perceived to be successful in the Canadian context. The first Canadian action plan on AMR was released in 1997 with the goal of reducing overall antimicrobial prescriptions by 25% within three years ([@R16]). Unfortunately, the lack of complete antimicrobial use data from 1995 to 1999 impeded efforts to estimate the full impact of this plan ([@R13]). Although early estimates suggested that the 1997 action plan was beginning to have an impact ([@R8]), it is unclear to what extent the government\'s call to action was implemented or sustained. A study of national programs undertaken from 1995 to 2010 described four major AMR programs in Canada during that time ([@R9]), and other ad hoc programs have been launched since 2010. The Canadian Committee on Antibiotic Resistance, which was established during this period to perform a collating and coordinating role for stakeholder groups across Canada, published a series of reports and action plans highlighting AMR challenges in Canada but was disbanded in 2009 following funding cuts ([@R8]; [@R25]; [@R26]). We now lack a current description of Canadian policy interventions addressing AMR. We undertook this environmental scan to identify and catalogue recent Canadian policy interventions on AMR, with the aim of better understanding existing AMR efforts across the country and critically evaluating whether Canada has taken sufficient action to mitigate this important threat.

Methods
=======

Policy interventions
--------------------

We defined policy intervention as any public- or community-focused intervention to reduce AMR or inappropriate antimicrobial use in humans through education, restriction, incentivization, coercion, training, persuasion, changing of the physical or social context, modelling of appropriate behaviour or reduction of barriers to action, in accordance with the Behaviour Change Wheel ([@R24]; [@R37]). National, provincial/territorial and local interventions were included; however, clinical interventions and interventions focused on individual hospitals, pharmacies and other healthcare facilities were not included.

Data collection
---------------

### Survey

We circulated a short e-mail questionnaire to identify AMR policy interventions between 2008 and 2018. This e-mail questionnaire asked respondents (1) if they were aware of any policy interventions related to AMR or antimicrobial use in Canada during the specified period, (2) when and where these interventions were undertaken, (3) what their goals were and (4) whom we could contact to obtain more details about the policies. We used purposive sampling to ensure a range of responses from federal, provincial, territorial and municipal levels and across human health sectors; e-mails were sent to a judgment sample of 253 experts who, in our view, were likely to be aware of AMR programs operating in Canada as a result of their professional roles. We anticipated that experts would potentially identify the same policies, and given our multistream approach to data collection, our sampling strategy prioritized geographic representation and professional representation above response rate. This sample included members of Canada\'s AMR Steering Committee, Council of Chief Medical Officers, academic researchers and representatives from health professional associations (medical, dental, pharmacy and nursing), regulatory colleges, hospitals and federal, provincial, territorial and municipal governments. Experts were encouraged to forward our e-mail to anyone who they thought might be able to provide relevant insights. E-mails in English and French were sent in February 2018, and follow-ups were sent two weeks after the initial e-mails. Where additional information was needed, we followed up with the respondent and conducted targeted Web searches.

### Systematic Literature Search

We conducted a systematic search for published literature on interventions to change antimicrobial use in Canada. In consultation with three research librarians from health science, social science and the government, we developed a structured search query to capture published evaluations of interventions that aimed to reduce antimicrobial use. Seven electronic databases from medicine and the social sciences (MEDLINE, CINAHL, Embase, PAIS Index, Cochrane Central Register of Controlled Trials, Web of Science and PubMed articles not indexed in MEDLINE) were searched from inception to January 28, 2019, without language or date limits. The full search strategy has been published elsewhere ([@R36]). We limited the search strategy to records that included the term "Canada" or named a province or territory in the abstract, author affiliations or keywords, and which were published after 2008. One author (Susan Rogers Van Katwyk) reviewed the abstracts and full texts of these studies to identify the ones that described a Canadian policy intervention between 2008 and 2018.

### Review of Government and Policy Literature

Finally, we conducted a grey literature search for policy and government documents on AMR. We conducted targeted Web searches of the Government of Canada website and targeted Google searches for "antimicrobial resistance" combined with the names of the provinces and territories. Additional grey literature sources were identified by key informants. We reviewed the reference lists of identified documents to identify other grey literature sources. We also requested a list of all funding announcements related to AMR between 2008 and 2018 from the Canadian Institutes of Health Research (CIHR).

Analysis
--------

For each identified policy intervention, we attempted to identify the intervention region, setting, time frame, goals and affiliated organizations. Regions were coded by province/territory, or as a national effort if the policy had a broader reach. We coded interventions as communication, legislation, service provision, regulation, fiscal, guideline and environmental and social planning interventions in accordance with the policy categories of the Behaviour Change Wheel ([@R24]) and our recent systematic review ([@R37]). The communications category was subdivided into educational programs and campaigns, events, action plans and communication tools.

We did not collect demographic data about survey respondents, as they were not the focus of this research project. Respondents\' geographic location and professional affiliation were known from the development of our judgment sample, and we report on the distribution of these characteristics. Respondents who were affiliated with multiple types of bodies (e.g., government officials who held academic appointments) were coded according to their primary affiliation. The University of Ottawa Office of Research Ethics and Integrity determined that ethics approval was not required for this project.

Results
=======

Thirty-seven experts responded to the survey, including at least one respondent from every province and territory, except Newfoundland and Labrador. Experts represented federal (*n* = 3), provincial (*n* = 8) and regional (*n* = 4) governments, as well as academia (*n* = 4), medicine (*n* = 5), nursing (*n* = 4), pharmacy (*n* = 4), dentistry (*n* = 2), veterinary medicine (*n* = 2) and civil society (*n* = 3). CIHR launched 14 funding calls on AMR from 2008 to 2018. Our structured literature review identified 235 studies that included the term "Canada" or named a province or territory. Ultimately, we identified six studies that reported evaluations of Canadian policy interventions between 2008 and 2018 ([@R12]; [@R14]; [@R23]; [@R1]; [@R29]; [@R40]). Our grey literature search identified an additional 63 government and policy documents that were screened to identify policy interventions in Canada between 2008 and 2018; a full list of these sources is provided in Appendix 1 ([available here](https://www.longwoods.com/articles/images/06-HPL-15-4-VanKatwyk-Appendix1.pdf)). Figure [1](#FG1){ref-type="fig"} summarizes our three streams of data collection, and [Box 1](#B1){ref-type="boxed-text"} shows a timeline of key actions, statements and policy papers in Canada between 2008 and 2018.
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###### Timeline of key AMR events and reports, 2008--2018

  Date       Event
  ---------- ---------------------------------------------------------------------------------------------------------------------------------------------
  Jan 2011   The Public Health Agency of Canada identifies antimicrobial resistance as one of the most significant public health risks facing Canadians.
  Mar 2013   Ontario Medical Association release policy paper: When Antibiotics Stop Working
  May 2014   Canadian Paediatric Society release position statement: Antimicrobial Stewardship in Daily Practice
  Jun 2014   Canadian Public Health Association release a Statement of Concern on Antimicrobial Resistance
  Oct 2014   Antimicrobial Resistance and Use in Canada: A Federal Framework for Action released
  Oct 2014   Expert Advisory Group on Antimicrobial Resistance established
  Jan 2015   Global Health Security Agenda identifies AMR as a priority; Canada a leading country
  Mar 2015   Federal Action Plan on Resistance and Use in Canada: Building on the Federal Framework for Action
  Apr 2015   Auditor General Report on AMR --- "Significant work remains to be done"
  Apr 2015   Canadian Federation of Medical Students and Students for Antimicrobial Stewardship Society release policy paper
  Oct 2015   Canada and G7 Health Ministers commit to strengthening antibiotic stewardship programs for professionals in medical and vet fields
  Oct 2015   Canada joins Transatlantic Task Force on AMR
  Jan 2016   AMR endorsed as a priority at the "Canadian Health Ministers\' Meeting"
  Apr 2016   HealthcareCAN report: Building Canada\'s Antimicrobial Stewardship Action Plan
  Apr 2016   Pan-Canadian Public Health Network release report: Antimicrobial Stewardship Report
  Jul 2016   COA, CDA and AMMI release consensus statement: Dental Patients with Total Joint Replacements
  Nov 2016   Canada announces \$9 million to WHO to support implementation of the GAP
  Nov 2016   Canadian Institutes of Health Research hosts Multi-Stakeholder Antimicrobial Stewardship Expert Forum
  Jan 2017   Canadian Paediatric Society re-affirm position statement: Antimicrobial Stewardship in Daily Practice
  Aug 2017   Tackling Antimicrobial Resistance and Antimicrobial Use: A Pan-Canadian Framework for Action
  Oct 2017   Canada becomes Chair of the Global Health Security Agenda AMR Action Package
  May 2018   HESA presents: A Study on the Status of Antimicrobial Resistance in Canada and Related Recommendations to the House of Commons
  Jul 2018   Government Response to HESA Study: A Study on the Status of Antimicrobial Resistance in Canada and Related Recommendations
  Jul 2018   Progress Report on the 2015 Federal Action Plan on Antimicrobial Resistance and Use

Note: COA: Canadian Orthopaedic Association; CDA: Canadian Dental Association; AMMI: Association of Medical Microbiology and Infectious Disease; GAP: Global Action Plan; HESA: House of Commons Standing Committee on Health

Altogether, we identified 52 programs active in Canada at some point between 2008 and 2018. The distribution of programs by region is shown in Figure [2](#FG2){ref-type="fig"}; at least one program was identified in all provinces and territories, except Nova Scotia, New Brunswick and Newfoundland and Labrador; however, more than half of the identified interventions were organized at the national level (*n* = 33). Programs varied considerably in size and reach, from a one-page leaflet, to a series of tweets, to a fully integrated regional-level stewardship program. As such, a higher number of implemented interventions does not necessarily indicate increased action or focus on AMR.
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Between 2008 and 2018, CIHR announced 14 grant calls related to AMR and awarded \$32.5 million to 77 teams ([Box 1](#B1){ref-type="boxed-text"}). These awards were to promote research in strategic areas, ranging from clinical and biological aspects of resistance to social science and global governance efforts. Many of these funding efforts have been in partnership with foreign governments: directly with the UK in 2008--2010, and, more recently, through the Joint Programming Initiative on AMR (JPIAMR). (Box 2 is [available here](https://www.longwoods.com/articles/images/06-HPL-15-4-VanKatwyk-Tables.pdf).)

The most commonly identified interventions (*n* = 29) were communication interventions. Other identified interventions were guidelines (*n* = 9), regulations (*n* = 7), service provision (*n* = 5) and fiscal measures (*n* = 2). We did not identify any AMR-focused legislation or environmental and social planning programs. Among the included interventions, we are aware of five that have been quantitatively evaluated ([@R12]; [@R14]; [@R23]; [@R29]; [@R40]).

Communication interventions
---------------------------

Among the communication interventions, we identified 16 educational programs, largely public awareness campaigns targeting health professionals and the public Table 1, [available here](https://www.longwoods.com/articles/images/06-HPL-15-4-VanKatwyk-Tables.pdf)). Many of the identified programs were provincial or regional variations on well-known programs such as "Do Bugs Need Drugs?" "Bugs and Drugs" or the annual Antibiotic Awareness Week. The Do Bugs Need Drugs? program has been linked to improvement in clinical knowledge of appropriate antibiotic treatment ([@R23]), and an ecological study has linked the program to declines in antimicrobial prescribing ([@R14]). Other smaller programs included radio broadcasts from the Northern Antibiotic Resistance Partnership, Twitter campaigns co-led by the Association of Medical Microbiology and Infectious Disease and the National Collaborating Centre for Infectious Disease and events organized by the Students for Antimicrobial Stewardship Society, a program organized by health professional students.

We identified three national frameworks and action plans released by the [@R31], [@R32] and 2017 ([@R17]). We also identified a provincial action plan that was in development in Quebec at the time of our survey, but no details were available. Three short educational events (1 to 2 days) were identified, two of which were hosted by CIHR and one by Health PEI. The remaining communication interventions included leaflets, posters and other tools to engage patients in discussions about antimicrobial use and to provide physicians with up-to-date information on antimicrobial prescribing.

Fiscal measures
---------------

We identified two fiscal policies (Table 2, [available here](https://www.longwoods.com/articles/images/06-HPL-15-4-VanKatwyk-Tables.pdf)), but neither provided funding for AMR action within Canada. The federal government provided \$250,000 to support the World Bank in writing a report on AMR ([@R39]) and committed \$9 million to the World Health Organization to support the development of national action plans in low- and middle-income countries.

Guidelines
----------

We identified nine guideline interventions, seven of which were released by the federal or provincial governments, and two of which were collaborations among health professional associations (Table 3, available online at [available here](https://www.longwoods.com/articles/images/06-HPL-15-4-VanKatwyk-Tables.pdf)). Guidelines were released in response to the development of resistance in particular pathogens of concern, including methicillin-resistant *Staphylococcus aureus* and extensively drug-resistant *Neisseria gonorrhoeae*. A rigorous quasi-experimental evaluation of the effectiveness of introducing these new gonorrhea guidelines in Ontario found that uptake of the revised treatment guidelines was very slow. Following the release of new guidelines, the proportion of physicians prescribing according to treatment guidelines dropped by over 60% and never returned to pre-intervention levels ([@R12]).

Regulations
-----------

We identified seven regulation interventions from 2008 to 2018 in Canada (Table 4, [available here](https://www.longwoods.com/articles/images/06-HPL-15-4-VanKatwyk-Tables.pdf)). The largest among these interventions was a regulation by Accreditation Canada requiring hospitals and long-term care facilities to have an antimicrobial stewardship program to receive accreditation. Only two regulations were identified at the level of the federal government: Health Canada implemented a regulation requiring a standard statement about AMR to be included on the drug monographs of all antibiotics, and Correctional Services Canada is in the process of developing a stewardship program for implementation in all their facilities.

Service provision
-----------------

We identified five service provision interventions (Table 5, [available here](https://www.longwoods.com/articles/images/06-HPL-15-4-VanKatwyk-Tables.pdf)), two from Ontario and three from British Columbia. All five interventions provided education and training sessions on antimicrobial stewardship within the health system, often including audit and feedback on antimicrobial use rates. Three programs were delivered by, or in partnership with, provincial governments. Two programs were delivered in partnership with regional health units.

Discussion
==========

Principal findings
------------------

AMR is among the top global threats facing humanity. Yet, the efforts identified in this environmental scan are too few, too small and too uncoordinated to meaningfully address this global threat. Our scan suggests that 10 years of AMR efforts in Canada have mostly consisted of a disjointed series of small projects that are inadequate to meet the Government of Canada\'s own AMR goals. Governments at all levels have prioritized small, education-based programs, rather than making use of the more powerful regulatory, fiscal and legislative policy levers at their disposal. Furthermore, the programs identified are not all based on scientific evidence or evaluated using rigorous scientific methods. There is only limited evidence that public awareness campaigns are effective at reducing antimicrobial use in the long term ([@R10]; [@R30]), and there is no evidence that shows what program elements make an effective public awareness campaign ([@R37]). Indeed, at least one study showed that passively providing patients with information through posters and leaflets is ineffective ([@R19]).

We believe Accreditation Canada\'s regulatory approach requiring all hospitals and long-term care facilities to implement antimicrobial stewardship programs is potentially more effective at reducing antimicrobial use. Although evidence that accreditation leads to improved care is weak ([@R2]), there is strong evidence that antimicrobial stewardship is effective ([@R11]). A rigorous evaluation of Accreditation Canada\'s program would be useful, particularly if it could identify the most effective components of a stewardship program. Other evidence-informed actions are the service provision efforts by the British Columbia Ministry of Health and Health Quality Ontario to provide audit and feedback on antimicrobial use to health professionals and long-term care facilities ([@R21]).

We found relatively few references to clinical practice guidelines in this scan. Although we recognize that our search strategy may have missed examples of clinical practice guidelines, we note that guidelines are an important component of an AMR response. To respond to growing AMR, guidelines need to be regularly updated, widely disseminated and rapidly adopted by health professionals, although the simple production of guidelines without corresponding dissemination and implementation efforts is insufficient to address AMR ([@R12]; [@R18]).

We identified few published or planned evaluations of policy effectiveness, and it was often unclear why an intervention was expected to work. For example, to the best of our knowledge, there is no evidence to suggest that placing warning labels about AMR on product monographs will change patient or professional behaviour. Although experimenting with new policies and strategies is essential for responding to AMR, policies planned without clear theories of change are unlikely to be effective.

Our findings suggest a surprising lack of engagement with AMR from key actors, including health professional associations and regulatory colleges. The Association of Medical Microbiology and Infectious Disease Canada is involved in many AMR efforts across Canada, and the College of Family Physicians of Canada has partnered with Choosing Wisely Canada on the Antibiotics Wisely campaign. Beyond these examples, we found only a few statements of concern released by the medical associations, and a guideline statement from the Canadian Dental Association. An effective, coordinated AMR response will require substantially more effort to integrate professional associations and bodies from medicine, dentistry, nursing and pharmacy.

The federated nature of the Canadian health system makes the provinces and territories responsible for regulating health professionals and antimicrobial use. The Office of the Auditor General of Canada ([@R27]) found that the PHAC had not yet succeeded in mobilizing all federal, provincial and territorial partners and stakeholders toward a Pan-Canadian Strategy on AMR. We saw limited evidence that Canadian provinces were independently pursuing regulatory approaches to addressing AMR. Provincial government responses have largely focused on educational campaigns and prescribing guidelines, and, as far as we are aware, only Quebec is developing a provincial AMR action plan. The lack of action or action plans from other provinces and territories emphasizes the need for increased commitment, coordination and collaboration among government actors. The forthcoming Pan-Canadian Action Plan on AMR should provide a platform for increasing collaboration across levels of government; however, fulfilling the obligations of this action plan will require more action from provinces and territories than has been seen to date.

Policy implications
-------------------

Despite the activities catalogued in this environmental scan, the rates of community antimicrobial use in Canada have been stable since 2013 ([@R33]). Increasing resistance highlights the extent to which the resources committed to AMR are incommensurate with the scale of the collective action problem. AMR represents a major threat to the sustainability of the Canadian healthcare system and requires substantially more focused investment and attention. Although Canada has taken on AMR leadership roles abroad, the level of political engagement, funding and regulatory and legislative action on AMR in Canada appears to be limited. Although PHAC provides routine funding for AMR surveillance and awareness campaigns, our scan did not identify any announcements of new domestic funding beyond CIHR research grants.

Framing AMR as a problem of individual patient and prescriber behaviour has unsurprisingly led to a series of AMR responses focused on education. This strategy recognizes that providers are more likely to prescribe antibiotics when patients request them ([@R5], [@R6]; [@R22]). However, antibiotic prescribing is also shaped by a series of health systems factors and social determinants of health, such as healthcare access, clinic volume, socio-economic status and patient--provider trust ([@R7]; [@R15]; [@R35]).

There are many policy approaches that have not been tried in Canada ([@R37]), including several legal, regulatory and fiscal strategies. To address AMR effectively, we need to make full use of these more powerful strategies and build a coordinated, evidence-based suite of policies to address AMR at multiple levels. Recent calls from CIHR and JPIAMR to fund social science and behaviour change research on AMR may lead to useful new strategies, and all policy interventions should be paired with appropriately rigorous evaluation plans to better inform resource allocation and shared learning across provinces and territories. As a starting point, provinces and territories should focus on improving and harmonizing the collection of data on AMR and antimicrobial use across the country, which will facilitate future evaluation efforts. The forthcoming Pan-Canadian Action Plan on AMR may provide the necessary platform for the federal and provincial governments to pursue a much ambitious AMR strategy. Future AMR action must move beyond simply integrating existing public communications campaigns and tools and toward effective, integrated, regulatory, legislative and fiscal measures.

Strengths and limitations
-------------------------

This report adds to the growing literature on AMR inaction in Canada. By surveying experts across Canada, we have captured data on AMR policy efforts at the national, provincial and territorial levels and those organized by academics and civil society. Although we aimed to be comprehensive through our combination of questionnaire, grey literature and published literature searching, some policies and programs may not have been captured if these were not identified by experts and if their Web resources were no longer available. We received responses from only 37 of our 235 experts and are more likely to have missed policies in regions or professions where we received fewer responses. This purposive sampling strategy focused on experts who currently hold positions where they would be aware of AMR programs in Canada; however, it is possible that we missed earlier programs because of staff turnover. We did not attempt to contact people who had moved on from their expert positions in the public health community. Similarly, online grey literature searching privileges recent sources over older documentation, particularly for defunct organizations such as the Canadian Committee on Antibiotic Resistance, whose Web resources have been removed. We have attempted to overcome these limitations by combining research strategies and, to the best of our ability, verifying our information through other sources. Finally, we chose to limit the scope of this study to policy interventions to reduce human antimicrobial use. We recognize that the Health Canada\'s Veterinary Drugs Directorate has made policy changes on antimicrobial use in animals that were not included in this report.

Conclusions
===========

AMR is a major threat to public health and healthcare in Canada. Our review suggests that the AMR interventions in Canada over the past 10 years have been too few, too small and too uncoordinated to adequately address the threat posed by AMR. Increased commitment to AMR, including multisectoral inter-agency cooperation and funding, is needed to ensure that future interventions are effective, evidence-informed and sufficient for Canada to overcome this looming threat.
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